David Schenkein
David Schenkein has told the board of Foundation Medicine he will not stand for reelection during the company's annual shareholders' meeting. He will retire from the board effective as of the date of the meeting. Schenkein is a member of the audit committee.
Patrick Balthrop
Agendia has appointed Patrick Balthrop, former CEO of Luminex, as non-executive chairman. Balthrop is a director at Oxford Immunotec, Personalis, and Concert Genetics. He's also an advisor to Water Street Healthcare Partners and the Founding Principal of Apalachee Ventures, an investment and advisory firm.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.